BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung cancer
,
Intestine
,
Metabolism of nitric oxide
,
Valproic acid
,
rs6983267
,
EGFR
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TET2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Skin
Ileum mucosa
Penis
Colon mucosa
Endometrium
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Sepsis due to Streptococcus agalactiae
Systemic infection
Systemic sclerosis
Turner syndrome
Muscle cachexia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
indole
monobutyl phthalate
Phlorhizin
Pyrrolidines
Argon
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
GNPTAB
IRAK4
HMGN3
COX2
MAP2K4
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Cell of origin epigenetic priming determines susceptibility to Tet2 mutation.
The role of TET2 in solid tumors and its therapeutic potential: a comprehensive review.
Recurrent Aortic Thromboembolism Associated With TET2 Mutation in Chronic Myelomonocytic Leukemia.
Tet2 acts in the lateral habenula to regulate social preference in mice.
RNA m5C oxidation by TET2 regulates chromatin state and leukaemogenesis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis
Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations
TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic A…
A Phase Ib/IIa Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermedia…
Collection of Biological Data With Potential Prognostic Relevance in Patients With MYELODYSPLASTIC S…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ